Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Studies compare time to ESRD in aHUS patients treated with supportive care or eculizumab

Nov. 24, 2014

Pharmacological profile of a novel PDE10A inhibitor, MT-3014

Nov. 24, 2014

In vivo protection with inactivated dengue virus antigens plus alphavirus adjuvant

Nov. 24, 2014

A genetically attenuated P. falciparum as vaccine candidate

Nov. 24, 2014

New murine models to study human hepatitis viral infection described at AASLD meeting

Nov. 24, 2014

Initial report on first-in-human study of 3-V Bioscience's TVB-2640

Nov. 24, 2014

Evacetrapib improves cholesterol efflux in patients with dyslipidemia

Nov. 21, 2014

Activity of novel PEGylated anti-IL-17A aptamer tested in models of rheumatoid arthritis

Nov. 21, 2014

First demonstration of clinical activity of AG-120 a first-in-class inhibitor of mutated IDH1

Nov. 21, 2014

ARMOR2 results: activity of galeterone in CRPC with AR-V7 variant

Nov. 21, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...